Department of Pediatric Respiratory Medicine and Allergy, Emma Children's Hospital, Academic Medical Centre, Amsterdam, The Netherlands.
Clinical and Experimental Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
Allergy. 2015 Aug;70(8):963-72. doi: 10.1111/all.12630. Epub 2015 May 18.
Cow's milk allergy (CMA) is one of the most commonly reported childhood food problems. Community-based incidence and prevalence estimates vary widely, due to possible misinterpretations of presumed reactions to milk and differences in study design, particularly diagnostic criteria.
Children from the EuroPrevall birth cohort in 9 European countries with symptoms possibly related to CMA were invited for clinical evaluation including cows' milk-specific IgE antibodies (IgE), skin prick test (SPT) reactivity and double-blind, placebo-controlled food challenge.
Across Europe, 12 049 children were enrolled, and 9336 (77.5%) were followed up to 2 years of age. CMA was suspected in 358 children and confirmed in 55 resulting in an overall incidence of challenge-proven CMA of 0.54% (95% CI 0.41-0.70). National incidences ranged from 1% (in the Netherlands and UK) to <0.3% (in Lithuania, Germany and Greece). Of all children with CMA, 23.6% had no cow's milk-specific IgE in serum, especially those from UK, the Netherlands, Poland and Italy. Of children with CMA who were re-evaluated one year after diagnosis, 69% (22/32) tolerated cow's milk, including all children with non-IgE-associated CMA and 57% of those children with IgE-associated CMA.
This unique pan-European birth cohort study using the gold standard diagnostic procedure for food allergies confirmed challenge-proven CMA in <1% of children up to age 2. Affected infants without detectable specific antibodies to cow's milk were very likely to tolerate cow's milk one year after diagnosis, whereas only half of those with specific antibodies in serum 'outgrew' their disease so soon.
牛奶过敏(CMA)是最常见的儿童食物问题之一。由于对牛奶的疑似反应和研究设计的差异(特别是诊断标准),基于社区的发病率和患病率估计值差异很大。
来自 9 个欧洲国家的 EuroPrevall 出生队列的有疑似与 CMA 相关症状的儿童被邀请进行临床评估,包括牛奶特异性 IgE 抗体(IgE)、皮肤点刺试验(SPT)反应和双盲、安慰剂对照食物挑战。
在整个欧洲,共招募了 12049 名儿童,其中 9336 名(77.5%)随访至 2 岁。358 名儿童疑似 CMA,55 名儿童确诊 CMA,总确诊率为 0.54%(95%CI 0.41-0.70)。各国的发病率从 1%(荷兰和英国)到<0.3%(立陶宛、德国和希腊)不等。所有 CMA 儿童中,23.6%的血清中无牛奶特异性 IgE,尤其是来自英国、荷兰、波兰和意大利的儿童。在确诊一年后再次评估的 CMA 儿童中,69%(22/32)耐受牛奶,包括所有非 IgE 相关 CMA 儿童和 57%的 IgE 相关 CMA 儿童。
这项独特的泛欧出生队列研究使用食物过敏的金标准诊断程序,在 2 岁以下儿童中确诊的 CMA 不足 1%。无可检测的牛奶特异性抗体的受影响婴儿在诊断后一年很可能耐受牛奶,而只有一半的血清中存在特异性抗体的婴儿很快就“摆脱”了疾病。